Treatment of hypertriglyceridemia and HIV: Fenofibrate-induced changes in the expression of chemokine genes in circulating leukocytes

AIDS Research and Therapy

Volumn 6, Issue , 2009, Pages

  Alonso Villaverde, Carlos ^a   Aragonès, Gerard ^a   Beltrán Debón, Raúl ^a   Fernández Sender, Laura ^a   Rull, Anna ^a   Camps, Jordi ^a   Alegret, Josep M ^a   Joven, Jorge ^a  

^a HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; FENOFIBRATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE COURSE; DRUG EFFECT; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTRIGLYCERIDEMIA; LEUKOCYTE; PRIORITY JOURNAL; VIRUS LOAD;

EID: 80052255779     PISSN: None     EISSN: 17426405     Source Type: Journal    
DOI: 10.1186/1742-6405-6-26     Document Type: Article

References (11)

1. Reiche EM, Bonametti AM, Voltarelli JC, Morimoto HK, Watanabe MA. Genetic polymorphisms in the chemokine and chemokine receptors: impact on clinical course and therapy of the human immunodeficiency virus type 1 infection (HIV-1). Curr Med Chem 2007, 14:1325-1334. 10.2174/092986707780597934, 17504215.
2. Depairon M, Chessex S, Sudre P, Rodondi N, Doser N, Chave JP, Riesen W, Nicod P, Darioli R, Telenti A, Mooser V, . Swiss HIV Cohort Study Premature atherosclerosis in HIV-infected individualsfocus on protease inhibitor therapy. AIDS 2001, 15:329-334. 10.1097/00002030-200102160-00005, 11273212, Swiss HIV Cohort Study.
3. Alonso-Villaverde C, Coll B, Parra S, Montero M, Calvo N, Tous M, Joven J, Masana L. Atherosclerosis in patients infected with HIV is influenced by a mutant monocyte chemoattractant protein-1 allele. Circulation 2004, 110:2204-2209. 10.1161/01.CIR.0000143835.95029.7D, 15466648.
4. Hadigan C, Meigs JB, Corcoran C, Rietschel P, Piecuch S, Basgoz N, Davis B, Sax P, Stanley T, Wilson PW, D'Agostino RB, Grinspoon S. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis 2001, 32:130-139. 10.1086/317541, 11118392.
5. Rao A, D'Amico S, Balasubramanyam A, Maldonado M. Fenofibrate is effective in treating hypertriglyceridemia associated with HIV Lipodystrophy. Am J Med Sci 2004, 327:315-318. 10.1097/00000441-200406000-00003, 15201643.
6. Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, Manninen V, et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 1987, 317:1237-1245. 10.1056/NEJM198711123172001, 3313041.
7. Lee JW, Bajwa PJ, Carson MJ, Jeske DR, Cong Y, Elson CO, Lytle C, Straus DS. Fenofibrate represses interleukin-17 and interferon-gamma expression and improves colitis in interleukin-10-deficient mice. Gastroenterology 2007, 133:108-123. 10.1053/j.gastro.2007.03.113, 17631136.
8. Schulz C, Schäfer A, Stolla M, Kerstan S, Lorenz M, von Brühl ML, Schiemann M, Bauersachs J, Gloe T, Busch DH, Gawaz M, Massberg S. Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: a critical role for P-selectin expressed on activated platelets. Circulation 2007, 116:764-773. 10.1161/CIRCULATIONAHA.107.695189, 17679613.
9. Cheng C, Tempel D, van Haperen R, de Boer HC, Segers D, Huisman M, van Zonneveld AJ, Leenen PJ, Steen A, Serruys PW, de Crom R, Krams. Shear stress-induced changes in atherosclerotic plaque composition are modulated by chemokines. J Clin Invest 2007, 117:616-626. 10.1172/JCI28180, 1794116, 17304353.
10. Simmons G, Reeves JD, Hibbitts S, Stine JT, Gray PW, Proudfoot AE, Clapham PR. Co-receptor use by HIV and inhibition of HIV infection by chemokine receptor ligands. Immunol Rev 2000, 177:112-126. 10.1034/j.1600-065X.2000.17719.x, 11138769.
11. Coll B, Alonso-Villaverde C, Parra S, Montero M, Tous M, Joven J, Masana L. The stromal derived factor-1 mutated allele (SDF1-3'A) is associated with a lower incidence of atherosclerosis in HIV-infected patients. AIDS 2005, 19:1877-1883. 10.1097/01.aids.0000183516.22266.dd, 16227796.